2015
DOI: 10.1586/17474124.2016.1125290
|View full text |Cite
|
Sign up to set email alerts
|

Circulating microRNAs in nonalcoholic fatty liver disease

Abstract: Summary Liver biopsy is currently recognized as the most accurate method for diagnosing and staging nonalcoholic fatty liver disease (NAFLD). However, this procedure is typically performed when disease has progressed to clinically significant stages, thereby limiting early diagnosis of patients who are at high risk for development of liver- and cardiovascular-related morbidity and mortality. Recently, microRNAs (miRNAs), short, noncoding RNAs that regulate gene expression, have been associated with histologica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
18
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(18 citation statements)
references
References 27 publications
0
18
0
Order By: Relevance
“…Studies have suggested that miRNAs play a role in the development of NAFLD . Specifically, circulating miR‐122, miR‐192, and miR‐22 have been proposed as biomarkers of NASH . The miRNAs are positively correlated with plasma ALT levels and considered as better NASH biomarkers than ALT .…”
Section: Discussionmentioning
confidence: 99%
“…Studies have suggested that miRNAs play a role in the development of NAFLD . Specifically, circulating miR‐122, miR‐192, and miR‐22 have been proposed as biomarkers of NASH . The miRNAs are positively correlated with plasma ALT levels and considered as better NASH biomarkers than ALT .…”
Section: Discussionmentioning
confidence: 99%
“…80 Conversely, the investigation of urinary miRNAs in liver disorders has been performed only in the oncologic field.…”
Section: Livermentioning
confidence: 99%
“…Mi-RNAs, short, non-coding RNAs that regulate gene expression, have been associated with histological features of NAFLD and are readily detected in the circulation. [31][32][33][34][35] The current study showed a significant increase in the level of mi-RNA-122 in NAFLD patients compared to controls, and its level is associated with disease severity from simple steatosis to steatohepatitis. This finding is in agreement with Jampoka et al, 36 who found that serum mi-RNA-122 levels in NAFLD patients were significantly higher than those found in the control group.…”
Section: Discussionmentioning
confidence: 95%